Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

National Cancer Institute (NCI) · clinicaltrials
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
anaplastic large cell lymphoma, alk-negative, anaplastic large cell lymphoma, alk-positive, apocrine carcinoma, carcinoma arising from cylindroma, carcinoma arising from spiradenoma, digital papillary adenocarcinoma

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 18594 · SHA-256 17c3746fc8cd5ac2
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.